President Trump issued an executive order to fast-track psychedelic therapies like ibogaine to treat PTSD and other mental ...

The state of Arizona is investing millions in the nation’s first clinical trial using whole psilocybin mushrooms to treat ...

FDA commissioner Marty Makary told NBC News that the first psychedelic drug could be approved in the U.S. as soon as this ...

It's a big shift toward supporting psychedelic-based medicines for treatment-resistant depression, PTSD and substance use ...

Trump signed an executive order on April 18, 2026, directing the FDA and DEA to fast-track research and approval of ibogaine ...

President Trump signed an executive order to fast-track the study of using psychedelic drugs to treat Americans – especially ...

Utah authorizes a state-funded clinical trial studying psychedelic-assisted therapy for veterans with treatment-resistant ...

“There’s a need for this because there’s been sort of rumblings in the scientific community that psychedelic medications may ...

Utah has approved a $1 million state-funded clinical trial to study psychedelic-assisted therapy for veterans with treatment-resistant PTSD. Conducted at the University of Utah’s Huntsman Mental ...

This naturally occurring substance, derived from an African shrub, has been used to treat PTSD, brain trauma, depression, ...

InvestigateTV+ examines a drug off-limits to science for decades that could be the key to treating first responders battling ...

The FDA has introduced a new fast-track review system for three psychedelic drug programs targeting PTSD and depression, potentially cutting approval review times to one or two months once ...